Neuronetics (STIM) Amortization of Deferred Charges (2017 - 2026)
Neuronetics (STIM) reported Amortization of Deferred Charges of $300000.0 for Q1 2026, up 50.0% year-over-year from $200000.0 in Q1 2025, and up 33.93% quarter-over-quarter from $224000.0 in Q4 2025.
Neuronetics (STIM) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Amortization of Deferred Charges data on file, last reported at $300000.0 in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $300000.0, up 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $924000.0 (up 16.81% YoY), and the FY2025 annual result was $824000.0, up 6.87% from the prior year.
- Amortization of Deferred Charges improved to $300000.0 in Q1 2026 per STIM's latest filing, from $224000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $300000.0 in Q2 2024 and troughed at $100000.0 in Q2 2023.
- A 5-year average of $182529.4 and a median of $196000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges plunged 50.0% in 2023, then jumped 200.0% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $196000.0 in 2022, then fell by 28.57% to $140000.0 in 2023, then surged by 36.43% to $191000.0 in 2024, then gained by 17.28% to $224000.0 in 2025, then surged by 33.93% to $300000.0 in 2026.
- Business Quant data shows STIM's Amortization of Deferred Charges at $300000.0 in Q1 2026, $224000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Dec 31, 2023 | 140,000.00 |